Companies/JP/4512

わかもと製薬株式会社 · WAKAMOTO PHARMACEUTICAL CO.,LTD.

Last · Tokyo¥298.00-3.00 (-1.00%)close · yahoo · 7h ago
Vol 49.8K ≈ 14.84M
Market cap¥10.3B34.7M sh
P/E · TTM30.2fwd — · eps 9.88
Beta0.45vs S&P 500
Div yield1.17%annual · TTM
52w range
¥240.00¥380.00
Volume49.8Ksession

Issuer

Legal nameWAKAMOTO PHARMACEUTICAL CO.,LTD. · わかもと製薬株式会社
HQJapan (JP)
ListingJP 4512
ISINJP3991200001
SectorHealthcare
IndustryPharmaceuticals
CurrencyJPY
Entity registryedinet:E00928
Org IDE00928
Employees403
AddressWakamoto Pharmaceutical Co., Ltd. 2-2-2 Nihonbashi Hon-cho 103-8330, Tokyo
Headline financial metrics
Revenue¥9.9B
Operating income¥255.5M
Net income¥227.2M
Free cash flow¥-924.9M
Operating margin2.6%
Net margin2.3%
Return on equity2.1%
Period2026
Loading chart…

OpenFilings analyst

Our analyst

ANNUAL · 2026-06-18

From latest ANNUAL · 2026-06-18

  • Operating Cf Burn

Red flags

  • Operating Cf Burn — Negative operating cash flow

Documents

FormReporting forFiledFlags
2026-08-202026-08-270
—2026-06-250
2026-03-312026-06-18 1
2026-03-312025-11-13 1